FDA 483 - Eric Jonasch, M.D. - March 05, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of clinical investigator Eric Jonasch, M.D. in Houston, TX, from February 24 to March 5, 2021, revealed significant deficiencies in maintaining adequate and accurate case histories. The observations included failures in contemporaneously reporting source data for study subjects and a lack of documentation regarding birth control methods. These issues highlight concerns with data integrity and adherence to proper record-keeping practices in clinical investigations.
ID · bfa21355-c952-4638-a28e-985bfddbf9cf